ATE205202T1 - Imidazol-, triazol- und tetrazolderivate - Google Patents

Imidazol-, triazol- und tetrazolderivate

Info

Publication number
ATE205202T1
ATE205202T1 AT93905531T AT93905531T ATE205202T1 AT E205202 T1 ATE205202 T1 AT E205202T1 AT 93905531 T AT93905531 T AT 93905531T AT 93905531 T AT93905531 T AT 93905531T AT E205202 T1 ATE205202 T1 AT E205202T1
Authority
AT
Austria
Prior art keywords
pct
nitrogen
represent
date sep
triazole
Prior art date
Application number
AT93905531T
Other languages
English (en)
Inventor
Victor Giulio Matassa
Austin John Reeve
Helen Routledge
Francine Sternfeld
Leslie Joseph Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929205482A external-priority patent/GB9205482D0/en
Priority claimed from GB929215731A external-priority patent/GB9215731D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE205202T1 publication Critical patent/ATE205202T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Paints Or Removers (AREA)
  • Lubricants (AREA)
AT93905531T 1992-03-13 1993-03-05 Imidazol-, triazol- und tetrazolderivate ATE205202T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929205482A GB9205482D0 (en) 1992-03-13 1992-03-13 Therapeutic agents
GB929215731A GB9215731D0 (en) 1992-07-24 1992-07-24 Therapeutic agents
PCT/GB1993/000474 WO1993018029A1 (en) 1992-03-13 1993-03-05 Imidazole, triazole and tetrazole derivatives

Publications (1)

Publication Number Publication Date
ATE205202T1 true ATE205202T1 (de) 2001-09-15

Family

ID=26300519

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905531T ATE205202T1 (de) 1992-03-13 1993-03-05 Imidazol-, triazol- und tetrazolderivate

Country Status (8)

Country Link
US (1) US5510362A (de)
EP (1) EP0630374B1 (de)
JP (1) JP3309982B2 (de)
AT (1) ATE205202T1 (de)
AU (1) AU669160B2 (de)
CA (1) CA2129146A1 (de)
DE (1) DE69330713T2 (de)
WO (1) WO1993018029A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
EP0759918A1 (de) * 1994-05-19 1997-03-05 MERCK SHARP & DOHME LTD. Indol-3-ylalkyl-piperidin-piperazin, -piperidin und tetrahydropyridin-derivate als 5-ht1 d-alpha agonisten
GB9410031D0 (en) * 1994-05-19 1994-07-06 Merck Sharp & Dohme Therapeutic agents
US5552402A (en) * 1994-05-19 1996-09-03 Merck, Sharp & Dohme Ltd. Five-membered heteroaromatic compounds as 5-HT receptor agonists
EP0804434A1 (de) * 1994-08-02 1997-11-05 MERCK SHARP & DOHME LTD. Azetidin, pyrrolidin-und piperidinderivate
GB9423460D0 (en) * 1994-11-21 1995-01-11 Merck Sharp & Dohme Therapeutic agents
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5770742A (en) * 1996-05-16 1998-06-23 Allelix Biopharmaceuticals Inc. Thiophene-tryptamine derivatives
AU2004210711B2 (en) * 2003-02-12 2010-07-08 Transtech Pharma, Inc. Substituted azole derivatives as therapeutic agents
WO2005080346A1 (en) * 2004-02-12 2005-09-01 Transtech Pharma, Inc. Substituted azole derivatives, compositions, and methods of use
ES2594874T3 (es) * 2004-11-18 2016-12-23 Synta Pharmaceuticals Corp. Compuestos de triazol que modulan la actividad de HSP90
CA2618628C (en) * 2005-08-18 2014-11-18 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
EP1991544B1 (de) * 2006-01-30 2018-08-15 vTv Therapeutics LLC Substituierte imidazol- derivate und ihre verwendung als ptpase inhibitoren
TWI490212B (zh) 2006-05-25 2015-07-01 Synta Pharmaceuticals Corp 調節hsp90活性之三唑化合物
US20080027047A1 (en) * 2006-05-25 2008-01-31 Weiwen Ying Compounds that modulate HSP90 activity and methods for identifying same
JP5441691B2 (ja) 2006-05-25 2014-03-12 シンタ ファーマシューティカルズ コーポレーション Hsp90活性を調節するトリアゾール化合物
CA2653222A1 (en) 2006-05-25 2007-12-06 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
WO2009102761A1 (en) * 2008-02-12 2009-08-20 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
US9205086B2 (en) 2010-04-19 2015-12-08 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
WO2013067162A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
AU2012332424A1 (en) 2011-11-02 2014-06-05 Synta Pharmaceuticals Corp. Combination therapy of Hsp90 inhibitors with platinum-containing agents
WO2013074594A1 (en) 2011-11-14 2013-05-23 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with braf inhibitors
MA42145B1 (fr) 2015-05-20 2020-05-29 Amgen Inc Triazoles agonistes du récepteur apj
EP3452466B1 (de) 2016-05-03 2020-08-12 Amgen Inc. Heterocyclische triazolverbindungen als agonisten des apj-rezeptors
US11046680B1 (en) 2016-11-16 2021-06-29 Amgen Inc. Heteroaryl-substituted triazoles as APJ receptor agonists
WO2018093577A1 (en) 2016-11-16 2018-05-24 Amgen Inc. Cycloalkyl substituted triazole compounds as agonists of the apj receptor
EP3541803B1 (de) 2016-11-16 2020-12-23 Amgen Inc. Triazolpyridylverbindungen als agonisten des apj-rezeptors
EP3541802B1 (de) 2016-11-16 2025-01-01 Amgen Inc. Alkylsubstituierte triazolverbindungen als agonisten des apj-rezeptors
US10906890B2 (en) 2016-11-16 2021-02-02 Amgen Inc. Triazole phenyl compounds as agonists of the APJ receptor
EP3541792B1 (de) 2016-11-16 2020-12-23 Amgen Inc. Triazol-furan-verbindungen als agonisten des apj-rezeptors
CN110636846B (zh) 2017-05-17 2023-05-16 艾库斯生物科学有限公司 用于治疗癌症相关疾病的喹唑啉吡唑衍生物
WO2019089335A1 (en) 2017-11-03 2019-05-09 Amgen Inc. Fused triazole agonists of the apj receptor
EP3788037A1 (de) 2018-05-01 2021-03-10 Amgen Inc. Substituierte pyrimidinone als agonisten des apj-rezeptors
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Gpr84アンタゴニストおよびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
CZ288351B6 (en) * 1990-06-07 2001-05-16 Astrazeneca Ab Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi

Also Published As

Publication number Publication date
EP0630374A1 (de) 1994-12-28
JPH07504431A (ja) 1995-05-18
EP0630374B1 (de) 2001-09-05
JP3309982B2 (ja) 2002-07-29
DE69330713D1 (de) 2001-10-11
DE69330713T2 (de) 2002-07-04
CA2129146A1 (en) 1993-09-16
AU669160B2 (en) 1996-05-30
US5510362A (en) 1996-04-23
WO1993018029A1 (en) 1993-09-16
AU3642893A (en) 1993-10-05

Similar Documents

Publication Publication Date Title
DE69330713D1 (de) Imidazol-, triazol- und tetrazolderivate
CA2238140A1 (en) Imidazole, triazole and tetrazole derivatives
ATE178065T1 (de) Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonisten
HU9300618D0 (en) Imidazole derivatives containing biphenyl-sulfonyl-urea side chain or biphenyl-sulfonyl-urethane one as well as method for producing them and their utilization
PL311204A1 (en) Indole derivatives as antagonists of 5-ht-like receptors for use in hemicrania
YU173791A (sh) Indol i benzimidazol-supstituisani imidazol i benzimidazol derivati
DE69329727D1 (de) Neue imidazol derivate, ihre herstellung und therapeutische verwendung
TR199900389T2 (xx) �kame edilmi� 6,5-hetero-bisiklik t�revleri.
DE69325662D1 (de) Dopamin rezeptor subtyp liganden
HU9300593D0 (en) Indole derivatives and pharmaceutical preparatives containing them as active agents
DE69419917D1 (de) Indazolderivate
NZ508560A (en) Use of prostaglandin agonists to treat erectile dysfunction or impotence
PL330408A1 (en) Dihydrobenzopyrane and affinite compounds useful as antiinflammatory agents
SE9201076L (sv) Användningen av gamla läkemedel för behandling av diabetes
DE69726437D1 (de) Benzothiophenderivate, ihre herstellung und verwendung als urokinase-inhibitoren
MY108739A (en) Imidazole, triazole and tetrazole derivatives
KR930016419A (ko) 치환된 이미다졸 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties